insights_auto
Why is FATE down 4.48%?
Dive Deeperchevron_right
FATE:NASDAQ
Fate Therapeutics Inc
$1.28
arrow_downward
-4.48%(-0.060) 1D
$1.26
arrow_downward
-1.56% (-0.020)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FATE...
Open
$1.32
High
$1.33
Low
$1.21
Mkt. cap
155.61M
Avg. vol.
1.46M
Volume
1.81M
52-wk high
$3.23
52-wk low
$0.95
EPS
-$1.03
Beta
2.65
Shares outstanding
121.57M
No. of employees
161
Open
$1.32
High
$1.33
Low
$1.21
Mkt. cap
155.61M
Avg. vol.
1.46M
Volume
1.81M
52-wk high
$3.23
52-wk low
$0.95
EPS
-$1.03
Beta
2.65
Shares outstanding
121.57M
No. of employees
161
News stories
From web sources and news partners
Investing.com Canada
·
1 day ago
Form 424B5 Fate Therapeutics Inc For: 13 November By Investing.com
About Fate Therapeutics Inc
CEOScott Wolchko
Employees161
Founded2007
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitefatetherapeutics.com